Amkor Technology
AMKR
$50.30
+4.90%
Amkor Technology is the world's largest pure-play outsourced semiconductor assembly and test (OSAT) provider, packaging and testing integrated circuits for semiconductor companies, foundries, and electronics OEMs across two product categories: advanced products (flip chip, wafer-level processing, advanced SiPs, power modules) and mainstream wirebond packaging and testing. As a critical back-end manufacturing partner rather than a chip designer, Amkor occupies a distinct position in the semiconductor value chain, with the majority of revenue derived from advanced packaging and from customers located outside the United States. The current investor narrative centers on the company's deepening strategic partnership with TSMC and its role as a beneficiary of AI-driven advanced packaging demand, which drove a dramatic re-rating of the shares through mid-2026. That enthusiasm has since collided with a sharp post-July drawdown and a mixed analyst reception, leaving investors to debate whether the AI packaging opportunity justifies the stock's premium multiple or whether the recent volatility reflects a more cautious demand outlook.…
AMKR
Amkor Technology
$50.30
Related headlines
Investment Opinion: Should I buy AMKR Today?
Based on the synthesis of analyst targets, valuation, and growth trajectory, the recommendation is a Hold with a bias toward accumulation on weakness. The core thesis is that Amkor's advanced packaging business is a key beneficiary of AI demand, but the stock's premium valuation and thin margins warrant caution until margin recovery is evident. The analyst consensus average target of $76.40 implies 52% upside, but the recommendation field is 'none' and institutional ratings are split, with JP Morgan and Needham bullish while Morgan Stanley and Goldman Sachs are neutral.
The supporting evidence includes revenue growth of 27.5% year-over-year in Q1 2026, a forward PE of 17.9x that is 31% below the trailing PE of 26.1x, and a PS ratio of 1.45x that is near the low end of its historical range. However, profitability is weak with a net margin of 5.57% and gross margin of 14.0%, and free cash flow turned negative in Q1 2026. The balance sheet is solid with debt-to-equity of 0.35 and a current ratio of 2.27, providing some downside protection.
The biggest risks that could invalidate the thesis are a failure to expand margins, a slowdown in AI-driven demand, and the stock's high beta of 2.232 amplifying market downturns. The rating would upgrade to Buy if gross margins sustainably exceed 16% and free cash flow turns positive, or downgrade to Sell if revenue growth decelerates below 10% or if the stock breaks below the $42.73 support level. Relative to its history and peers, the stock appears fairly valued on sales but overvalued on earnings unless the margin recovery materializes.
Sign up to view all
AMKR 12-Month Price Forecast
The forward-looking view is neutral with medium confidence. Amkor's advanced packaging business is well-positioned to benefit from AI demand, as evidenced by 27.5% revenue growth and the TSMC partnership. However, the company's thin margins, negative free cash flow, and premium valuation on earnings present significant risks. The analyst consensus target of $76.40 suggests upside, but the split ratings and high beta indicate uncertainty. An upgrade to bullish would require sustained gross margin expansion above 16% and positive free cash flow, while a downgrade to bearish would occur if revenue growth decelerates below 10% or if the stock breaks below $42.73.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Amkor Technology's 12-month outlook, with a consensus price target around $76.40 and implied upside of +51.9% versus the current price.
Average Target
$76.40
0 analysts
Implied Upside
+51.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $92
Analyst target range
Coverage is moderate, with 10 analysts publishing targets. The consensus average target price is $76.40, which implies roughly 52% upside from the current $50.30 — a strikingly bullish gap that reflects how far the stock has fallen below where the sell-side believes fair value lies. The recommendation field is listed as "none," but the underlying institutional ratings skew constructive: JP Morgan maintains Overweight, Needham maintains Buy, while Morgan Stanley and Goldman Sachs hold Equal Weight/Neutral and B. Riley stays Neutral. The consensus therefore leans moderately bullish, but with a clear split between AI-optimists and valuation-conscious holdouts.
The target range is wide, from a low of $65.00 to a high of $92.00, a spread of 42% that signals meaningful disagreement about the company's trajectory. Notably, even the lowest target sits 29% above the current price, meaning no covering analyst models downside from here — a configuration that typically follows a sharp selloff that analysts view as overdone. The high target of $92.00 implies a return toward the June highs and assumes sustained AI-driven advanced packaging demand, successful ramp of the TSMC partnership, and margin expansion back toward mid-teens gross margins. The low target of $65.00 still prices in a recovery but with more modest multiple expansion and slower margin normalization. The institutional ratings history shows no downgrades in 2026 — actions have been reiterations rather than changes — which suggests analysts are holding their ground through the volatility rather than capitulating, though the absence of fresh upgrades also indicates limited near-term catalysts to force a re-rating.
Bulls vs Bears: AMKR Investment Factors
The bull case rests on Amkor's re-accelerating revenue growth of 27.5% year-over-year, a forward PE of 17.9x that implies significant earnings growth, and a consensus analyst target of $76.40 representing 52% upside. The bear case highlights thin and volatile margins, negative free cash flow in Q1 2026, and a high beta of 2.232 that has contributed to a 54.3% maximum drawdown. Currently, the bear evidence appears stronger on a near-term basis due to the severe technical damage and margin volatility, but the bull case has substantial support from analyst targets and the TSMC partnership. The single most important tension is whether the AI-driven advanced packaging demand can drive sustainable margin expansion; if gross margins recover toward the mid-teens or higher, the forward PE will prove justified, but if margins remain depressed, the valuation is at risk.
Bullish
- Revenue re-accelerating at 27.5% YoY: Q1 2026 revenue of $1.685 billion grew 27.5% year-over-year from $1.321 billion in Q1 2025, a sharp acceleration from the prior-year comparison. This growth is driven by the advanced products segment, which contributed $1.372 billion, or roughly 81% of total revenue, and is directly tied to AI and high-performance computing demand.
- Analyst targets imply 52% upside: The consensus average target price of $76.40 implies approximately 52% upside from the current $50.30, with even the lowest target of $65.00 sitting 29% above the current price. This configuration, where no covering analyst models downside, typically follows a sharp selloff that analysts view as overdone.
- Forward PE compression signals earnings growth: The trailing PE of 26.1x compares with a forward PE of 17.9x, a roughly 31% compression that implies the market expects earnings to grow substantially over the next twelve months. This is consistent with the 27.5% revenue growth and margin recovery embedded in consensus estimates.
- TSMC partnership validates AI packaging thesis: The major strategic partnership with TSMC, highlighted in recent news, positions Amkor as a key beneficiary of AI-driven advanced packaging demand. This partnership supports the advanced products segment, which is already the primary growth engine at 81% of revenue.
Bearish
- Thin and volatile margins: Q1 2026 gross margin was 14.19% and net margin was 4.95%, reflecting the capital-intensive, price-competitive nature of OSAT assembly and test. Margins have oscillated significantly, with gross margin ranging from 12.04% in Q2 2025 to 16.66% in Q4 2025, and net margin swinging from 9.10% in Q4 2025 to 4.95% in Q1 2026.
- Negative free cash flow in Q1 2026: Q1 2026 free cash flow was negative $79.5 million as capital expenditure of $224.6 million outpaced operating cash flow of $145.1 million. Trailing-twelve-month free cash flow of $167.2 million is modest against a $9.76 billion market cap, indicating the company is not yet generating sufficient internal cash to both invest at this pace and return capital comfortably.
- High beta and severe drawdown: The beta of 2.232 means Amkor is more than twice as volatile as the S&P 500, and the stock has experienced a 54.3% maximum drawdown from its 52-week high of $96.68. The shares are down 44.4% over three months, a stark divergence from the +72.5% one-year gain, signaling a sharp trend reversal.
- Premium valuation on earnings: The trailing PE of 26.1x sits in the upper-middle of its historical range of roughly 7x to 52x, and the PEG ratio of 5.38 warns that even the forward multiple is rich relative to the growth rate being priced in. The price-to-book of 2.18x is above the 1.07x-2.46x range seen over the past two years.
AMKR Technical Analysis
Amkor is in a recovery phase within a broader uptrend that has been violently interrupted. The stock is up 72.5% over the past year, yet at $50.30 it sits only about 32% of the way up its 52-week range of $28.03 to $96.68, having surrendered more than half its value from the July peak. That positioning is unusual: a strongly positive 1-year return paired with a price closer to the annual low than the high signals a momentum name that has been badly damaged but not broken, and the 54.3% maximum drawdown confirms how severe the correction has been. The 52-week high of $96.68 was set during the June AI-driven melt-up, so the current price reflects a market that has fully unwound that euphoria while still holding a substantial gain versus a year ago.
Short-term momentum is stabilizing but not yet repaired. The stock is down 1.16% over the past month and a punishing 44.4% over three months, a stark divergence from the +72.5% one-year gain that points to a sharp trend reversal rather than a routine pullback. The most recent action offers a tentative positive: the shares rallied 4.90% on the latest session to $50.30 from a prior close of $47.95, and the 1-month decline of 1.16% is far milder than the 3-month collapse, suggesting the selling pressure is decelerating. Relative strength tells the same story of a broken intermediate trend: -46.4% versus SPY over three months and -0.20% over one month, even as the 1-year relative strength remains a strong +57.5%.
Key technical levels are well defined by the 52-week range. Support sits at the $28.03 52-week low, with the July capitulation low of $42.73 and the August-September base around $45.70-$47.90 forming nearer-term floors; resistance is anchored at the $96.68 high, with the $60-$65 zone representing the first meaningful overhead supply from the July breakdown. A breakout above $65 would signal that the AI packaging thesis is reasserting itself, while a breakdown below $42.73 would confirm a deeper bear phase. Volatility is a critical risk-management consideration: the beta of 2.232 means Amkor is more than twice as volatile as the S&P 500, so position sizes should be roughly half of what a market-beta name would warrant, and the short ratio of 2.12 indicates a modest but non-trivial short base that could amplify moves in either direction.
Beta
2.23
2.23x market volatility
Max Drawdown
-54.3%
Largest decline past year
52-Week Range
$28-$97
Price range past year
Annual Return
+72.5%
Cumulative gain past year
| Period | AMKR Return | S&P 500 |
|---|---|---|
| 1m | -1.2% | -0.5% |
| 3m | -44.4% | +2.3% |
| 6m | +9.8% | +16.6% |
| 1y | +72.5% | +14.8% |
| ytd | +17.2% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMKR Fundamental Analysis
Amkor's revenue trajectory is re-accelerating after a soft patch. The most recent quarter (Q1 2026, ended March 31) delivered revenue of $1.685 billion, up 27.5% year-over-year from $1.321 billion in Q1 2025, a sharp acceleration from the prior-year comparison. The multi-quarter trend shows the recovery clearly: revenue climbed from $1.511 billion in Q2 2025 to $1.987 billion in Q3 2025, dipped seasonally to $1.888 billion in Q4 2025, then held at $1.685 billion in Q1 2026. Segment data confirms the mix is skewed toward higher-value work, with Advanced Products contributing $1.372 billion versus $313 million from Mainstream Products, meaning the AI- and high-performance-computing-linked advanced packaging business is roughly 81% of revenue and the primary growth engine.
Profitability is positive but thin and volatile, which is the central tension in the fundamental case. Q1 2026 net income was $83.4 million on a 4.95% net margin, with gross margin of 14.19% and operating margin of 6.97% — modest levels that reflect the capital-intensive, price-competitive nature of OSAT assembly and test. Margins have oscillated meaningfully: gross margin was 16.66% in Q4 2025, 14.32% in Q3 2025, and just 12.04% in Q2 2025, while net margin swung from 9.10% in Q4 2025 to 4.95% in Q1 2026. The sequential compression from Q4 to Q1 reflects both seasonality and the fixed-cost burden of a business carrying $170.9 million in quarterly depreciation and amortization against $1.685 billion of revenue, so utilization rates are the key swing factor for earnings.
Balance sheet and cash flow metrics are solid but show the strain of heavy investment. Debt-to-equity is a conservative 0.35, the current ratio is a healthy 2.27, and ROE is 8.36% with ROA of 4.62% — reasonable for a capital-intensive manufacturer. However, Q1 2026 free cash flow was negative $79.5 million as capital expenditure of $224.6 million outpaced operating cash flow of $145.1 million, and trailing-twelve-month free cash flow of $167.2 million is modest against a $9.76 billion market cap. Cash on hand stands at $1.189 billion, down from $1.378 billion at year-end 2025, so while the balance sheet can fund the current capex cycle, the company is not yet generating the internal cash to both invest at this pace and return capital comfortably.
Quarterly Revenue
$1.7B
2026-03
Revenue YoY Growth
+27.5%
YoY Comparison
Gross Margin
14.2%
Latest Quarter
Free Cash Flow
$167222000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMKR Overvalued?
Because Amkor is profitable — Q1 2026 net income of $83.4 million and trailing EPS of $0.038 — the PE ratio is the appropriate primary metric, though the trailing figure is distorted by the depressed earnings base. The trailing PE of 26.1x compares with a forward PE of 17.9x, a roughly 31% compression that implies the market expects earnings to grow substantially over the next twelve months, consistent with the 27.5% revenue growth and margin recovery embedded in consensus estimates. The PEG ratio of 5.38, however, warns that even the forward multiple is rich relative to the growth rate being priced in.
Against the broader semiconductor sector, Amkor screens as a low-multiple, low-margin name. Its PS ratio of 1.45x and EV/Sales of 1.62x are well below the multiples typically commanded by chip designers and equipment makers, reflecting the OSAT business model's thin 5.57% net margin and 14.0% gross margin. The EV/EBITDA of 8.56x is similarly modest for a semiconductor-linked business, and the price-to-book of 2.18x is unremarkable. The premium embedded in the forward PE therefore rests entirely on the earnings-recovery story rather than on any scarcity value in the multiple itself — if margins fail to expand toward historical peaks, the forward PE will prove optimistic.
Historical context shows the stock is not cheap by its own standards. Amkor's PE has ranged from roughly 7x to 52x over the past several years, and the current trailing 26.1x sits in the upper-middle of that band, while the PS ratio of 1.45x is near the low end of its historical range of roughly 2.0x to 6.8x — a discrepancy explained by the depressed earnings denominator. The price-to-book of 2.18x is above the 1.07x-2.46x range seen over the past two years, suggesting the market is capitalizing the AI packaging opportunity at a premium to book value even after the drawdown. Net-net, the valuation is not stretched on sales but offers little margin of safety on earnings unless the margin recovery materializes.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~53x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.6x
Enterprise Value Multiple
Investment Risk Disclosure
Amkor faces significant financial and operational risks stemming from its thin margins and capital-intensive model. Q1 2026 gross margin was only 14.19% and net margin 4.95%, with margins oscillating widely—gross margin ranged from 12.04% in Q2 2025 to 16.66% in Q4 2025. The company carries $170.9 million in quarterly depreciation and amortization against $1.685 billion of revenue, so utilization rates are a critical swing factor; a decline in utilization could quickly erode profitability. Additionally, Q1 2026 free cash flow was negative $79.5 million as capex of $224.6 million exceeded operating cash flow of $145.1 million, and trailing-twelve-month free cash flow of $167.2 million is modest relative to the $9.76 billion market cap, indicating limited financial cushion if demand softens.
Market and competitive risks are elevated due to Amkor's high beta of 2.232, which makes it more than twice as volatile as the S&P 500, and its premium valuation on earnings. The trailing PE of 26.1x is in the upper-middle of its historical range, and the PEG ratio of 5.38 suggests the forward multiple is rich relative to expected growth. The stock has already suffered a 54.3% maximum drawdown from its 52-week high of $96.68, and a breakdown below the July capitulation low of $42.73 could trigger further selling. Competitive pressures in the OSAT space, particularly from larger foundries expanding into advanced packaging, could compress margins and market share. Recent news highlights the TSMC partnership, but also warns of premium valuation and extended chart, suggesting volatility ahead.
The worst-case scenario involves a combination of slowing AI demand, margin compression, and a broader semiconductor downturn. If advanced packaging demand decelerates and gross margins fall back toward the 12% level seen in Q2 2025, earnings could disappoint, leading to analyst downgrades and multiple contraction. In this scenario, the stock could retest its 52-week low of $28.03, representing a decline of approximately 44% from the current price of $50.30. Even a move to the July low of $42.73 would imply a 15% loss. Given the high beta and negative free cash flow, the downside risk is substantial, and investors should be prepared for significant volatility.
FAQ
The key risks include financial, competitive, macro, and company-specific factors. Financially, thin margins (14.19% gross) and negative free cash flow (-$79.5 million in Q1 2026) limit flexibility. Competitively, larger foundries expanding into advanced packaging could pressure market share. Macro risks are amplified by a beta of 2.232, making the stock more than twice as volatile as the S&P 500. Company-specific risks include revenue concentration in advanced products (81% of revenue) and dependence on the AI cycle. The most severe risk is a demand slowdown leading to a retest of the 52-week low of $28.03.
The 12-month forecast includes three scenarios: a bull case with 30% probability targeting $76.40-$92.00, a base case with 50% probability targeting $65.00-$76.40, and a bear case with 20% probability targeting $28.03-$42.73. The base case is most likely, assuming moderate revenue growth of 15-20% and gradual margin improvement. The key assumption is that AI demand remains stable and the TSMC partnership ramps successfully. However, the wide target range reflects significant uncertainty.
AMKR appears fairly valued on sales but overvalued on earnings. The PS ratio of 1.45x is near the low end of its historical range of 2.0x to 6.8x, suggesting the market is not paying a premium for revenue. However, the trailing PE of 26.1x is in the upper-middle of its historical range, and the PEG ratio of 5.38 indicates the forward multiple is rich relative to expected growth. The valuation implies the market expects significant margin expansion and earnings recovery; if that fails to materialize, the stock could be overvalued.
From a risk/reward perspective, AMKR is a speculative buy for investors who believe in the AI packaging growth story and can tolerate high volatility. The analyst average target of $76.40 implies 52% upside, and the forward PE of 17.9x suggests earnings growth is expected. However, the biggest downside risk is a retest of the 52-week low of $28.03, which would represent a 44% loss. The stock is suitable for aggressive investors with a long-term horizon, but conservative investors should wait for margin recovery and positive free cash flow before considering a position.
AMKR is more suitable for long-term investment (minimum 2-3 years) given its growth stage and high volatility. The beta of 2.232 and 54.3% max drawdown make it risky for short-term trading, but the AI packaging opportunity is a multi-year secular trend. The company pays a small dividend with a yield of 0.84%, which is not a primary reason to hold. Earnings visibility is moderate, with analyst estimates for revenue of $11.72 billion. Short-term traders may find opportunities in the volatility, but long-term investors should focus on margin recovery and free cash flow generation.